IN8bio Stock Quote INAB - Stock Price, News, Charts, Message Board, Trades

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
IN8bio Inc (INAB) Quote

IN8bio Inc (INAB)

1.05

0.00

( 0.00% )

Updated: 10:30:28

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.05

Bid

1.05

Ask

1.06

Volume

101,188

1.02 Day's Range 1.09

0.65 52 Week Range 3.9499

Market Cap

Previous Close

1.05

Open

1.02

Last Trade

Last Trade Time

10:40:49

Financial Volume

$ 104,066

VWAP

1.0284

Average Volume (3m)

343,538

Shares Outstanding

43,287,325

Dividend Yield

-

PE Ratio

-1.51

Earnings Per Share (EPS)

-0.69

Revenue

-

Net Profit

-30.01M

IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.in8bio.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

IN8bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INAB. The last closing price for IN8bio was $1.05. Over the last year, IN8bio shares have traded in a share price range of $ 0.65 to $ 3.9499.

IN8bio currently has 43,287,325 shares outstanding. The market capitalization of IN8bio is $45.45 million. IN8bio has a price to earnings ratio (PE ratio) of -1.51.

IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced that...

IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024

- Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue - Gamma-delta nsCAR platform emerging as an advanced...

IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Reported the First-Ever Durable Persistence of an Allogeneic Cellular Therapy from a Phase 1 Study of INB-100 in Leukemia where 100% of Evaluable Patients (n=10) Treated Remained in Remission...

IN8bio to Present New Preclinical Data on Novel Gamma-Delta CAR Platform Candidate at AACR Annual Meeting 2024

New preclinical data demonstrating proof-of-concept for the non-signaling gamma-delta T cell CAR (nsCAR) platform candidate targeting CD-33 and CD-123 will be presented.The platform has...

IN8bio to Present at Upcoming Investor Conferences

IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and Co-founder, will...

IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ: INAB), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.06	-5.40540540541	1.11	1.14	0.9164	407102	1.06744969	CS
4	-0.2	-16	1.25	1.28	0.9164	698104	1.10801808	CS
12	-0.25	-19.2307692308	1.3	1.45	0.9164	343538	1.13135633	CS
26	0.1499	16.6537051439	0.9001	2.48	0.65	481365	1.39341974	CS
52	-0.18	-14.6341463415	1.23	3.9499	0.65	1226488	2.41266659	CS
156	-8.95	-89.5	10	10.319	0.65	600773	2.53912168	CS
260	-8.95	-89.5	10	10.319	0.65	600773	2.53912168	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGOXNext e GO NV	$ 0.067 (86.11%)	223.53M
NVFYNova Lifestyle Inc	$ 3.165 (50.00%)	10.14M
ZCMDZhongchao Inc	$ 2.1648 (49.30%)	26.6M
SHOTWSafety Shot Inc	$ 0.3998 (33.27%)	6.3k
RWODRedwoods Acquisition Corporation	$ 10.45 (30.68%)	5.26M
SBFMSunshine Biopharma Inc	$ 2.1399 (-35.55%)	6.31M
ISPCiSpecimen Inc	$ 0.3058 (-27.36%)	1.38M
BGLCBioNexus Gene Lab Corporation	$ 0.63 (-25.76%)	407.57k
YYAIConnexa Sports Technologies Inc	$ 1.57 (-24.88%)	3.45M
TIRXTian Ruixiang Holdings Ltd	$ 0.606 (-24.25%)	1.3M
EGOXNext e GO NV	$ 0.0665 (84.72%)	223.54M
AGBAAGBA Group Holding Ltd	$ 1.22 (18.45%)	81.41M
SQQQProShares UltraPro Short QQQ	$ 12.428 (2.97%)	64.18M
SINTSiNtx Technologies Inc	$ 0.0406 (1.50%)	38.76M
TQQQProShares UltraPro QQQ	$ 51.285 (-2.78%)	31M

Tyrus603

Tyrus603 1 week ago

Talk about a delayed effect. But once more investors fully absorb the news... How big is the leukemia prescribed drug treatment market? Sky high run still possible.

Laster

Laster 1 week ago

Sold my shares this morning that I bought last night for small loss.
Volume not great. No PM movement (yet).
Who knows. It may surprise and take off at 9:30 open.
If it does, then congrats to y’all.

Invest-in-America

Invest-in-America 1 week ago

INAB: Their Post-M news relates only PRE-Human findings, etc., at this point --- but, you simply publish a MAYBE-WE-GOT-A-POTENTIAL-CANCER-CURE type of PR and well, you know, a PRICE Moon landing tomorrow morning maybe??? (Holding circa 35% up in the Post-M, at this writing.)

BOTTOM LINE??? GO-GO-GO-INAB!!!!

glenn1919

glenn1919 1 month ago

INAB.........................https://stockcharts.com/h-sc/ui?s=INAB&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 2 months ago

murocman

murocman 4 months ago

Surprised how much this has tanked in light of stellar data?

Murocman

murocman

murocman 4 months ago

Outstanding data and financing in place to boot!

Should move up!

Murocman

Awl416

Awl416 4 months ago

IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia

Monksdream

Monksdream 7 months ago

Monksdream

Monksdream 7 months ago

INAB new 52 week low

Monksdream

Monksdream 7 months ago

INAB new 52 week low

The Night Stalker

The Night Stalker 10 months ago

https://stockcharts.com/h-sc/ui?s=inab&p=W&yr=0&mn=11&dy=25&id=p34307943936&a=1105106922&listNum=2

The Night Stalker

The Night Stalker 10 months ago

The Night Stalker

The Night Stalker 10 months ago

The Night Stalker

The Night Stalker 10 months ago

The Night Stalker

The Night Stalker 10 months ago

The Night Stalker

The Night Stalker 10 months ago

The Night Stalker

The Night Stalker 11 months ago

The Night Stalker

The Night Stalker 11 months ago

The Night Stalker

The Night Stalker 11 months ago

The Night Stalker

The Night Stalker 11 months ago

Mr Wick

Mr Wick 11 months ago

New INB 200 phase 1 data evaluating INB 200 patients will be available on Thursday 25 May. Also being presented at ASCO annual meeting on 02 June.
Fingers crossed.

The Night Stalker

The Night Stalker 11 months ago

MrMocha

MrMocha 11 months ago

I agree, INAB is going to do great things. A majority of their trials so far show great promise! I’m excited to see what their future holds..I can definitely see them being acquired in the not so distant future. Great find Mr Wick!

Mr Wick

Mr Wick 11 months ago

New to ihub. Found in8bio a few weeks ago after the huge run recently. After researching I told a friend that " in8bio might be the best sleeper stock I have ever seen".
Looking forward to a buyout.

The Night Stalker

The Night Stalker 11 months ago

The Night Stalker

The Night Stalker 11 months ago

Trons

Trons 11 months ago

Headed to $20 on cancer developments

Jess070283

Jess070283 12 months ago

Uh oh Shorts I’m trouble….

trendzone

trendzone 12 months ago

Real DUMBASS move by the company this mornings news of offerings, but with the other big news out this week, it's probably a screaming buy on the reversal selloff, and sellers are acting like the fools that they are.

Jess070283

Jess070283 12 months ago

Loading this dip for the rip…

Invest-in-America

Invest-in-America 12 months ago

INAB: It is CUTE!! (Hey, Boss, PBLA & INAB lookin' interesting; so too SAI, of course.)

TheFinalCD

TheFinalCD 12 months ago

Update: IN8bio's INB-400, INB-410 Secure US FDA's Orphan Drug Designation -- Shares Surge Premarket
HC Wainwright & Co. Reiterates Buy on IN8bio, Maintains $14 Price Target

subslover

subslover 12 months ago

Love your scanner! :)

2020Benzo

2020Benzo 12 months ago

Did they just post same Orphan Drug news twice in a row it’s sane PR !

TheFinalCD

TheFinalCD 12 months ago

surf1944

surf1944 12 months ago

https://stockcharts.com/h-sc/ui?s=inab&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/inab/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/inab/opinion

Back down to $1

ringo1

ringo1 12 months ago

Time to take some profits

Hercules1

Hercules1 12 months ago

It hit $3.95.

$4 break is coming.

$5 quite possible today.

Hercules1

Hercules1 12 months ago

Total beast.

Next stop $4.

And then $5.

Awl416

Awl416 12 months ago

Jess070283

Jess070283 12 months ago

Invest-in-America

Invest-in-America 12 months ago

INAB: Maybe I've gone BONKERS, but this little freak show could hit TEN-BUCKS-A-SHARE today, Peeps!!!! (At least that's what my 'SCANNER' just told me!! See below!!)

Hercules1

Hercules1 12 months ago

This skyrockets to $5 today.

This is just getting started.

Invest-in-America

Invest-in-America 12 months ago

INAB: Howdy, Herc!!! Guess us TWO chaps will have to PARTY all by ourselves over here today on this silly little iHub Board!! Heck, I guess nobody else but US two could figure-out what INAB's cute PR was all about!! (HA-HAAAAAAA!!!)

Lastly, check-out what my 'BROKER' (see below) had to say to me about this INAB stock, very early this morning:

Hercules1

Hercules1 12 months ago

Price target:

$14

News is absolutely huge.

Invest-in-America

Invest-in-America 12 months ago

INAB: This is iHub's legendary "INVEST-IN-AMERICA", with a very succinct DIRECT ORDER for INAB's entire High Seas Fleet --- to wit, OPEN-FIRE-NOW!!!

Invest-in-America

Invest-in-America 12 months ago

INAB: Might get a little run-up later today, when all of the insider dumping subsides. I mean heck, pretty decent PR.
https://seekingalpha.com/news/3959103-in8bio-stock-rises-cancer-drug-inb-100-shows-promise-phase-1-trial

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions